Medical Equipments, Pharmaceuticals And Personal Care Products Tenders

Purchase of Disposable Medical Instruments

Purchase of Disposable Medical Devices

Purchase of Medical Equipment

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Tofacitinib (L04aa29) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Aripiprazole, as a Depot Injection Suspension (N05ax12) - (Open House Model)

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Formoterol and Aclidinium Bromide (R03al05) as Part of an Open House Model.

Open House Biologics Rebate Contracts 2023-02 - Follitropin Beta

Open House Discount Contracts 2023-04

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Urapidil (C02ca06) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Baricitinib (L04aa37) as Part of a So-Called Open House Model.